CJC-1295 without DAC 5mg + Ipamorelin 5mg is a short-acting growth hormone support blend typically used where the main goals are improved recovery, better sleep quality, enhanced overnight repair, and broader body-composition support. Because both compounds are commonly used in pulse-based GH protocols, this blend is generally positioned as a more controllable option than longer-acting DAC-based formats.

It is most relevant where recovery, sleep, leaner body composition, and training support are the primary goals. It can be used as a simple once-daily recovery protocol or as a more active twice-daily structure where a stronger GH-support approach is recommended.

How It Works

CJC-1295 without DAC supports GH release through the GHRH pathway and is typically used where a shorter-acting, pulse-style release pattern is preferred.

Ipamorelin is commonly used as a selective GHRP to support GH release with a cleaner profile than older GHRPs.

Together, the blend is typically used to support:

• Sleep depth and overnight recovery
• Recovery from training wear-and-tear
• Leaner body composition over time
• Broader GH-support protocols where shorter-acting control is preferred

Reconstitution Guideline

Total vial content: 10mg

• CJC-1295 without DAC: 5mg
• Ipamorelin: 5mg

Suggested reconstitution: 2mL bacteriostatic water

Resulting concentration:

• CJC-1295 without DAC: 2.5mg/mL
• Ipamorelin: 2.5mg/mL

Dosage reference:

• 0.04mL = CJC 100mcg + Ipamorelin 100mcg
• 0.08mL = CJC 200mcg + Ipamorelin 200mcg
• 0.10mL = CJC 250mcg + Ipamorelin 250mcg
• 0.12mL = CJC 300mcg + Ipamorelin 300mcg
• 0.16mL = CJC 400mcg + Ipamorelin 400mcg

Dosage Protocol

This blend is commonly used in either a once-daily or twice-daily format depending on how aggressively the protocol is being run.

Standard Dosing

A typical standard protocol is:

• 200mcg of each compound once daily
• Timing: either AM fasted or before bed

At 2mL reconstitution, this equals:

• 0.08mL once daily

This is the most common practical entry point and suits general recovery, sleep support, and foundational GH-support use.

Aggressive Dosing

A more aggressive protocol is:

• 200–300mcg of each compound twice daily
• Timing: AM fasted and before bed

At 2mL reconstitution, this equals:

• 0.08mL twice daily for 200mcg / 200mcg
• 0.12mL twice daily for 300mcg / 300mcg

This structure is more relevant where recovery, body composition, or GH-support goals are being pushed more deliberately.

Common Timing Structures

AM Fasted

• Often used on waking, before food
• Common where body composition and daytime GH-support structure are priorities

Before Bed

• Often used as a simple recovery-focused option
• Common where sleep depth and overnight repair are the main priorities

AM Fasted + Before Bed

• Used in more aggressive protocols
• Common where broader recovery and body-composition support are both being targeted

Run Length

• 8 to 12 weeks for standard use
• Longer structured use is also common where the protocol is being kept controlled and consistent

Expected Outcomes

• Improved sleep depth and overnight recovery
• Better recovery from training wear-and-tear
• Support for leaner body composition over time
• Pulse-based GH support in a shorter-acting format
• A more structured recovery protocol than single-compound GH peptides alone

Stacking / Pairing

This blend is commonly positioned alongside:

• Fat-loss protocols where recovery quality needs to be maintained
• Recovery-focused blends where sleep and repair are central
• Physique-focused protocols where leaner body composition is part of the goal
• Restoration-focused products where broader recovery capacity is being supported

It works well as a foundation GH-support blend inside a wider recovery or body-composition plan.

Cautions

• Reconstituted product should be refrigerated after mixing.
• Sterile technique should be used during reconstitution and handling.
• A conservative starting dose is generally recommended.
• Short-acting protocols work best when dosing timing is consistent.
• Not suitable for use where contraindicated.